Evidence map›Paper›PMID 28056789›Full record

ArticleBMC microbiology2017

Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.

Emily V Davies, Chloe E James, Michael A Brockhurst, Craig Winstanley

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Intrapulmonary percussive ventilation improves lung function in cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa: a pilot cross-over study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Trial
  2. Long-term culturing ofApplied and environmental microbiology · 2025
    Article
  3. Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail againstPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  4. Diversification ofMicroorganisms · 2025
    Article
  5. What Is a Biofilm? Lessons Learned from Interactions with Immune Cells.International journal of molecular sciences · 2024
    Review
  6. Co-occurring microflora and mucin driveISME communications · 2024
    Article
  7. Biofilm-forming strains of P. aeruginosa and S. aureus isolated from cystic fibrosis patients differently affect inflammatory phenotype of macrophages.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  8. How to study biofilms: technological advancements in clinical biofilm research.Frontiers in cellular and infection microbiology · 2023
    Review
  9. Review
  10. Article
  11. Antimicrobial Peptides against Multidrug-ResistantJournal of medicinal chemistry · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Pathogens (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Emily V DaviesInstitute of Infection and Global Health, University of Liverpool, 8 West Derby Street, Liverpool, L69 7BE, UK.
Chloe E JamesInstitute of Infection and Global Health, University of Liverpool, 8 West Derby Street, Liverpool, L69 7BE, UK.
Michael A BrockhurstDepartment of Biology, University of York, York, YO10 5DD, UK.
Craig WinstanleyInstitute of Infection and Global Health, University of Liverpool, 8 West Derby Street, Liverpool, L69 7BE, UK. C.Winstanley@liv.ac.uk.ORCID 0000-0002-2662-8053
University of Liverpool · GBUniversity of York · GB

Funding

Medical Research CouncilWellcome TrustWellcome Trust 089215/Z/09/Z
6 · The paper itself

Abstract

backgroundDuring chronic lung infections of cystic fibrosis patients Pseudomonas aeruginosa populations undergo extensive evolutionary diversification. However, the selective drivers of this evolutionary process are poorly understood. To test the effects of temperate phages on diversification in P. aeruginosa biofilms we experimentally evolved populations of P. aeruginosa for approximately 240 generations in artificial sputum medium with or without a community of three temperate phages.

resultsAnalysis of end-point populations using a suite of phenotypic tests revealed extensive phenotypic diversification within populations, but no significant differences between the populations evolved with or without phages. The most common phenotypic variant observed was loss of all three types of motility (swimming, swarming and twitching) and resistance to all three phages. Despite the absence of selective pressure, some members of the population evolved antibiotic resistance. The frequency of antibiotic resistant isolates varied according to population and the antibiotic tested. However, resistance to ceftazidime and tazobactam-piperacillin was observed more frequently than resistance to other antibiotics, and was associated with higher prevelence of isolates exhibiting a hypermutable phenotype and increased beta-lactamase production.

conclusionsWe observed considerable within-population phenotypic diversity in P. aeruginosa populations evolving in the artificial sputum medium biofilm model. Replicate populations evolved both in the presence and absence of phages converged upon similar sets of phenotypes. The evolved phenotypes, including antimicrobial resistance, were similar to those observed amongst clinical isolates from cystic fibrosis infections.

Indexed as

BiodiversityBiological EvolutionPhenotypeBacteriophagesbeta-LactamasesBiofilmsCulture MediaCystic FibrosisDrug Resistance, MicrobialPenicillanic AcidPiperacillinPseudomonas aeruginosaPseudomonas InfectionsSputumTazobactambeta-LactamasesCulture MediaPenicillanic AcidPiperacillinTazobactamAntimicrobial resistanceBacteriophageBiofilmCystic fibrosisEvolutionMotilityPseudomonas aeruginosa

Identifiers

PMID28056789
PMCPMC5216580
OpenAlexW2570306095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.